Monthly Archives

November 2019

CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data

  • November 19, 2019
  • admin

Nov 19, 2019 CRISPR Therapeutics and Vertex Announce Positive Safety and Efficacy Data From First Two Patients Treated With Investigational CRISPR/Cas9... Continue Reading

Novartis Adakveo approved by FDA for Sickle Cell Disease

  • November 16, 2019
  • admin

New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease Sickle... Continue Reading